Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients.

Yoshihiro KanemitsuKensuke FukumitsuRyota KurokawaNorihisa TakedaYoshiyuki OzawaAyako MasakiJunya OnoKenji IzuharaJennifer Maries YapHirono NishiyamaSatoshi FukudaTakehiro UemuraTomoko TajiriHirotsugu OhkuboKen MaenoYutaka ItoTetsuya OguriMasaya TakemuraMotohiko SuzukiAkio Niimi

Published in: ERJ open research (2020)

Mould/SE sensitisation (≥0.10 UA·mL-1) may affect the development of Type 2 inflammation and clinical outcomes in CRS patients.

Keyphrases

end stage renal disease
staphylococcus aureus
ejection fraction
oxidative stress
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
escherichia coli
cystic fibrosis
patient reported